The Global Antipsychotic Drugs Market is touted to touch USD 18.5 billion at a staggering 4.3% CAGR over the predicted years (2016-2022). Psychosis is a disorder where the person may face serious distortion of behavior, thought, perception and recognition of reality. The patients may experience hallucinations and delusions along with having wrong evaluation and misperception of other people, facts or situations.
Psychosis is not a condition but rather gets triggered due to other conditions such as stress, traumatic experiences or physical conditions namely brain tumor, Parkinson’s disease or due to alcohol or drug misuse. Due of lack of insight, the person is unaware that he/she is acting and thinking strangely. Antipsychotic drugs also known as neuroleptics or major tranquilizers are used primarily for treating psychosis. Such drugs help in blocking the dopamine receptors in the brain’s dopaminergic pathways, thus repressing the dopamine’s effect that is linked directly to psychotic experiences. These drugs are used to treat common psychotic disorders including bipolar disorder, delusions, hallucinations, schizophrenia and others.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2784
Global Antipsychotic Drugs Market – Key Players
Some of the key players in this Antipsychotic Drugs Market are:
- Eli Lilly & Co.
- Bristol-Myers Squibb
- Pfizer inc.
- GlaxoSmithKline plc
- Johnson & Johnson
Dementia Training Australia of late has come up with a new tool that will assist all residential aged care providers in monitoring and reducing the utilization of antipsychotic medicines in facilities. The main objective of launching this tool is for improving practices on the use of medication particularly in aged care. All aged care health experts having experience in the antipsychotic medicines can have access to this tool that will enable providers in monitoring changes in their utilization of antipsychotic medicines for residents. The providers can assess the latest Aged Care Quality Standards soon, from 1st July 2019.
Global Antipsychotic Drugs Market – Regional Analysis
Globally America is the largest market for antipsychotic Drugs. The American market for antipsychotic drugs represents about 47 % of world market in 2016. Rapid uptake of new drug molecules and excellent reimbursements scenario in the U.S. are the two most important factors for the dominance of America. Europe is the second-largest market for antipsychotic drugs. Asia pacific region is expected to be fastest growing region in antipsychotic drugs market.
Global Antipsychotic Drugs Market – Segments
Market Research Future report offers an all-inclusive segmental analysis of the antipsychotic drugs market on the basis of application and generation.
Based on therapeutic application, it is segmented into dementia, depression, bipolar disorder, schizophrenia and others. Of these, psychotic depression and schizophrenia will have the largest share in the antipsychotic drugs market over the predicted years.
Based on generation, the Antipsychotic Drugs Market is segmented into first, second, third. The first generation is also called neuroleptics or typical antipsychotics and the second generation is also called atypical antipsychotics.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312